Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07813559

Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease

Sponsor: Tianjin Medical University

View on ClinicalTrials.gov

Summary

In the field of diagnosing Thrombi diseases, it is now a well established practice to inject positron-emitting tracers into the human body. These tracers bind to specific target proteins, allowing their distribution to be visualized via PET imaging. Currently, several research groups worldwide are engaged in developing and clinically validating their own GPIIb/IIIa imaging agents.

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2026-09-01

Completion Date

2031-09-01

Last Updated

2026-09-10

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

18F/68Ga-GP1

Each subject receive a single intravenous injection of 18F/68Ga-GP1, and undergo PET/ CT or MRI imaging within the specificed time.

Locations (3)

The First Affiliated Hospital of University of Science and Technology of China

Hefei, Anhui, China

The Affiliated Hospital of Qingdao University

Qingdao, Shandong, China

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China